Showing 2642 results
- Media Release /Biosimilar Tyruko® approved for all indications of reference medicine, with same dosing and administration schedule Sandoz continues to expand access to much-needed medications for patients…
- Media Release /Planned investment of approximately USD 90 million to build a state-of-the-art Sandoz Biosimilar Technical Development Center in Ljubljana, Slovenia by 2026New end-to-end drug substance and drug…
- Media Release /If approved, will be first-of-a-kind biosimilar natalizumab in Europe, for use in all indications of reference biologic Positive CHMP opinion based on evidence from extensive analytical…
- Statement /
Pagination
- ‹ Previous page
- 1
- …
- 164
- 165
- 166
- 167
- 168
- 169
- 170
- …
- 265
- › Next page